
               
               
               
                  CLINICAL PHARMACOLOGY

               
               
               
                  
                     
                     
                     
                        Pharmacokinetics

                     
                     
                        Gastrointestinal absorption of nystatin is insignificant. Most orally administered nystatin is passed unchanged in the stool. In patients with renal insufficiency receiving oral therapy with conventional dosage forms, significant plasma concentrations of nystatin may occasionally occur.
                     
                     
                  
               
               
                  
                     
                     
                        Microbiology 

                     
                     
                        Nystatin is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeastâ€“like fungi. Candida albicans demonstrates no significant resistance to nystatin in vitro on repeated subculture in increasing levels of nystatin; other Candida species become quite resistant. Generally, resistance does not develop in vivo. Nystatin acts by binding to sterols in the cell membrane of susceptible Candida species with a resultant change in membrane permeability allowing leakage of intracellular components. Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses.
                     
                     
                  
               
            
         